Meet man behind 71 hospitals and 5,000 pharmacies, at the age of 92 he still goes to office for..., his name is...
Meet man behind 71 hospitals and 5,000 pharmacies, at the age of 92 he still goes to office for…, his name is…
At the age of 92, when most of the elderly plan their hospital visits and have retired from active life, Dr. Prathap C. Reddy still goes to office, setting an example for younger generations. He reaches to office at sharp 10 am and clocks out at 5 pm, working six days a week. Reddy is the founder of Apollo Hospitals, which is India's first corporate hospital. His idea of starting a corporate hospital revolutionised the country's healthcare system, providing high-quality medical treatment to people. He dreamt of providing a world-class medical facility in India so that Indians didn't need to travel abroad for treatment. Let's know about Dr. Prathap C. Reddy. Who is Dr. Prathap C. Reddy?
Reddy was born in Chennai and completed his MBBS from Stanley Medical College. He then moved to America to train as a cardiologist. He had the opportunity to build a successful career overseas, but he returned to India after his father sent him a heartfelt letter in 1970s. Reddy's father requested him to return home and contribute to his country.
An incident in which a patient died in India due to a lack of medical facilities in 1979 deeply impacted Dr. Reddy. He decided to open a hospital to provide world-class treatment to people. This decision became the turning point in his life.
He started a single hospital, but over the years it has grown into a healthcare empire. Today, Apollo Hospitals operates as many as 71 hospitals in different parts of the country. Not only that, the brand has over 5,000 pharmacy outlets, 291 primary care clinics, and a digital health platform as well. Financial Giant
Apart from dominating the healthcare sector in India, Apollo Hospitals is also a financial giant, as the company has a market capitalisation of 70,000 crore. Dr. Reddy's family owns 29.3 percent of stake in the company. Dr. Prathap C. Reddy's Net Worth
According to Forbes, Dr. Reddy's net worth is approx Rs 26,560 crore.
Dr. Reddy's life is a reflection of ambition, compassion, and impactful action. His belief, expressed in a Business Today interview, that success necessitates humility and increased national contribution, remains central to his life at age 92. His career demonstrates that leadership transcends age, and lasting positive change defines genuine success.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Hindustan Times
19 minutes ago
- Hindustan Times
India's fight against Sickle Cell Disease
Every year, over 3,00,000 infants are born with Sickle Cell Disease (SCD) worldwide, a genetic blood disorder which brings serious health complications. The country holds the second-highest burden of the disorder globally. An estimated 20 million Indians are affected by SCD making it a public health concern that needs urgent attention. The condition gains seriousness because of the intensity of the disease – as many as 50-90 per cent of the young patients suffering from it do not even see their fifth birthday. Sickle Cell Disease affects millions in India, with a high mortality rate among young patients. The government mission Prioritising the health of tribal communities and recognising SCD as a serious public health challenge, the Government of India launched a National Sickle Cell Elimination Mission (NSCEM) in July 2023 with the goal to decimate the disease before the country celebrates Amrit Kaal in 2047. One of the main challenges in SCD is early detection, which is covered by one of the key objectives of the mission – universal screening. The mission also promotes community-based genetic counselling. This helps families understand the risks and prevent the transmission of SCD to future generations. In addition, the mission includes awareness and education campaigns for high-risk communities. A key part of this is a national media campaign titled 'India's Fight Against Sickle Cell: From Awareness to Action', led by and HealthShots in partnership with Novo Nordisk India. Flagged off on June 19, it will culminate in a conclave – National Sickle Cell Summit 2025 – at The Lalit, New Delhi on June 30, 2025. These initiatives are important for reducing stigma surrounding the disease, promoting better understanding, and encouraging timely medical intervention. The plan also involves strengthening health infrastructure, especially at the primary healthcare level, by improving diagnostic and treatment capabilities to improve access to care and free distribution of essential medicines like hydroxyurea and folic acid through public health centres. Finally, to support ongoing improvements, the government is committed to establishing a national SCD registry and investing in research to advance disease management and care practices. The inclusion of sickle cell screening under national health missions and the involvement of frontline health workers like ASHAs and ANMs in patient follow-ups demonstrate a growing commitment to early detection and continuous care. What is SCD? SCD is a chronic genetic disorder that alters the shape and function of red blood cells in the body, causing them to become sickle shaped, stiff, sticky. These abnormal cells can block blood flow, preventing oxygen from reaching tissues. This can lead to sudden and severe episodes known as 'pain crises' which can last for hours or even days in certain cases. Those with SCD also contend with ongoing health complications like chronic anaemia, joint pains, delayed growth, shortness of breath, and extreme fatigue. Over time, virtually every organ in the body can be affected, leading to issues such as stroke, kidney and liver dysfunction, vision problems and frequent infections. The disease is most common among tribal and other ethnic groups in specific regions, commonly known as the 'sickle cell belt', which include parts of Gujarat, Maharashtra, Rajasthan, Madhya Pradesh, Jharkhand, Chhattisgarh, West Bengal, Odisha, Tamil Nadu, Telangana, Andhra Pradesh, Karnataka, Assam, Uttar Pradesh, Kerala, Bihar and Uttarakhand. The way forward Since the launch of the campaign, about 5.85 crore individuals have already been screened for SCD. The figure reflects the momentum of the campaign, which is now operational in 17 states and 278 districts. Screening initiatives have been flagged off in schools and communities to identify those at risk and health workers are being trained to identify symptoms and counsel affected families. The government aims to cover about 7 crore individuals aged between 0 and 40 years across 278 districts in India. This screening is particularly focused on tribal districts, identified as high-risk for SCD, to ensure early and accurate identification of both individuals with the disease and carriers of the sickle cell trait and also improve the care and prospects of patients suffering from the disease. The program is being executed in a 'mission mode' as part of the National Health Mission (NHM) and its implementation partners include the Ministry of Health and Family Welfare (MoHFW), the Ministry of Tribal Affairs, Indian Council of Medical Research, State Governments and Tribal Health Departments. Note to reader: This article has been produced on behalf of the brand by HT Brand Studio and does not have the journalistic/editorial involvement of Hindustan Times. The information provided does not constitute medical advice. Please consult a registered medical practitioner for health-related concerns.
News18
25 minutes ago
- News18
Globe Civil Projects IPO Listing Tomorrow: What Does Latest GMP Signal?
Last Updated: The grey market premium of the Globe Civil Projects IPO currently stands at 36.62% over the IPO price., signalling strong listing gains for investors on Tuesday. Globe Civil Projects IPO Listing Date: As the allotment has been finalised, the Globe Civil Projects IPO is set to witness its stock market listing on Tuesday, July 1. Its latest grey market premium (GMP) of 36.6% indicates strong listing gains for investors. With GMP standing at Rs 26, the shares of Globe Civil Projects Ltd are likely to be listed at around Rs 97 apiece as against its IPO price of Rs 71 per share. According to market observers, the grey market premium, which shows investor sentiments towards the IPO, currently stands at 36.62% over the IPO price. It signals strong listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Globe Civil Projects IPO Listing Date The shares of Globe Civil Projects Ltd are set to be listed on the BSE and the NSE tomorrow, Tuesday, July 1, 2025. Globe Civil Projects IPO: Check Allotment Status The allotment of the Globe Civil Projects IPO was finalised on June 27. Investors can check their IPO allotment status on the websites of NSE, BSE or Kfin Technologies. The status can be checked by following these steps: 1) Go to the official BSE website via the URL — 2) Under 'Issue Type', select 'Equity'. 3) Under 'Issue Name', select 'Globe Civil Projects Ltd' in the dropbox. 4) Enter your application number, or the Permanent Account Number (PAN). 5) Then, click on the 'I am not a robot' to verify yourself and hit the 'Search' option. Your share application status will appear on your screen. You can also visit directly on the registrar Kfin Technologies' portal — and check the Globe Civil Projects IPO allotment status. The allotment status can also be checked on the NSE's website at Globe Civil Projects IPO: Subscription Status, Other Details The IPO was open for public subscription between June 24 and June 26. The Rs 119-crore IPO received an 80.97 times subscription, garnering bids for 94,99,76,860 shares as against the 1,17,32,392 shares on offer. The retail and NII participation stood at 53.67 times and 143.14 times, respectively. Its qualified institutional buyer (QIB) category got an 82.13 times subscription. The company's IPO is entirely a fresh issue of equity shares worth Rs 119 crore with no offer for sale (OFS) component. It proposes to utilise funds for working capital requirements, capex, and general corporate purposes. The quota for non-institutional investors garnered 8.16 times subscription, and the category for qualified institutional buyers (QIBs) subscribed 8.06 times. The portion for retail individual investors (RIIs) received 5.82 times the subscription. Its shares will be listed on BSE and NSE. Globe Civil Projects Ltd intends to utilise Rs 75 crore of the IPO proceeds for funding working capital requirements, Rs 14.26 crore for capital expenditure towards the purchase of construction equipment/machinery and the remaining funds will be used for general corporate purposes and issue expenses, according to a company statement.
NDTV
27 minutes ago
- NDTV
"Paid Rs 30 Lakh Taxes, Got Zero Support": Laid off Bengaluru Techie Says Falling Into Depression
A viral social media post by Venkatesh Alla has sparked a heated online debate about job safety in India. The post shares the story of Mr Salim, a top-performing engineer from a National Institute of Technology (NIT) who was laid off from a leading tech firm with a lucrative salary of Rs 43.5 lakh per annum. Notably, Mr Salim had paid over Rs 30 lakh in income tax over five years, including Rs 11.22 lakh in the last year alone, yet received zero support after losing his job. He was given only three months' severance pay by the company. Now unemployed, Mr Salim is relying on his severance pay and savings to fund his children's education, which costs Rs 1.95 lakh per child per year. "Now jobless, thankfully without a home loan, he's using his savings and severance to pay for his children's education, ₹1.95 lakh per child, per year. That's where his "reward" is going. Worse, he fell into depression. He said he felt like he was suddenly on the road, abandoned from every direction. The same government he paid lakhs to in taxes betrayed him the moment he needed it most," the post read. "This is what happens to genuine taxpayers in India. You pay. You comply. You contribute. And when you're in crisis, you're on your own. This country desperately needs to change. Because right now, it's failing the very people who carry it forward," the post added. See the post here: Just got a message from Mr. Salim a topper from his NIT, working in Bangalore with a ₹43.5 LPA package laid off last month. The company handed him just 3 months' severance. Last year alone, he paid ₹11.22 lakhs in income tax. In just 5 years, over ₹30 lakhs gone into the… — Venkatesh Alla (@venkat_fin9) June 29, 2025 The tweet has sparked a heated debate about the lack of support for India's salaried taxpayers, especially during crises. Several users advocated for key reforms, including structured unemployment benefits to provide financial support during job loss, mental health programs to address related emotional struggles, and tax reforms that offer tangible returns for salaried contributors, potentially providing a safety net in times of crisis. However, some users disagreed on whether the government should assist in such cases. One user commented, "You want the government to give him a job because he lost his job? Does this make any sense?" Another wrote, "This is the same everywhere in the world. The problem isn't taxation, it's the lack of long-term financial planning." A third said, "The only solution is to expand the tax base, bring more into the formal economy. Only then can we reduce the burden on the salaried middle class." A fourth added, "Layoffs are always a tragedy and it's difficult for young and brilliant minds to get fired. I hope the brilliant guy will get the job soon. But what's the relationship between getting fired and paying taxes? It happens all the time in US. India can't sustain the European model of unemployment payment."
